For condition: Atopic Dermatitis
For condition: Eczema – Atopic Dermatitis
Moderate to Severe Atopic Dermatitis Research Trial (77 Weeks)
Study Summary
Who Can Participate?
Adults 18 to 75 years of age (inclusive) with atopic dermatitis (AD), may be eligible to participate in this clinical research trial (sponsored by Kymera Therapeutics, Inc.).
Inclusion Criteria:
- Chronic atopic dermatitis that has been present for at least 3 years
- Moderate to severe AD
- At least 10% body surface area (BSA) of AD involvement (i.e. equal to 10 palm prints)
- 6-month history of either an inadequate response to, or contraindication to, topical medications
- Has been using an emollient twice daily for at least 1 week, and should continue using that same emollient throughout the study
Participant Info:
- No cost to participate or receive study medication
- Regular visits with study doctors who are familiar with treating AD
- Will receive investigational oral medication (active study drug) or placebo
- Reimbursement for time and travel to the clinic may be provided
How Long Will The Study Last?
Participation will last about 77 weeks and involve about 24 visits to the study research site.
For more information about this trial, please visit ClinicalTrials.gov
